Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

H pylori and host interactions that influence pathogenesis.

Ellen J Beswick, Giovanni Suarez, Victor E Reyes

    World Journal of Gastroenterology
    |September 29, 2006
    PubMed
    Summary

    Helicobacter pylori (H. pylori) is a widespread bacterial pathogen linked to gastritis, ulcers, and gastric cancer. This review explores how H. pylori virulence factors contribute to gastroduodenal disease despite host immune responses.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    EZH1/2 inhibition improves immunotherapy response through MHC Class II de-repression and neutrophil reprogramming.

    bioRxiv : the preprint server for biology·2026
    Same author

    Distinct Serum and Tissue Markers Predict Fibrosis in Crohn's Disease.

    Cells·2026
    Same author

    Inhibition of fatty acid synthase enhances therapeutic efficacy and delays acquired resistance to BRAF-targeted therapy in colorectal cancer.

    Neoplasia (New York, N.Y.)·2026
    Same author

    MK2 Inhibition as a Novel Treatment for Fibrosis in Primary Sclerosing Cholangitis via an IL-22-Dependent Mechanism.

    Cells·2025
    Same author

    A microRNA-regulated transcriptional state defines intratumoral CD8<sup>+</sup> T cells that respond to immunotherapy.

    Cell reports·2025
    Same author

    MK2 Inhibition in CD4+ T Cells Protects Against IFNγ and IL-17A, Chronic Inflammation, and Fibrosis in Inflammatory Bowel Disease Models.

    Inflammatory bowel diseases·2025

    Area of Science:

    • Microbiology
    • Immunology
    • Gastroenterology

    Background:

    • Helicobacter pylori (H. pylori) is the most common human pathogen globally, implicated in gastritis, peptic ulcer disease, and gastric cancer.
    • Initially identified in 1983, H. pylori infections are often acquired early in life and can persist lifelong.
    • Despite chronic inflammation and adaptive immune responses, the host cannot clear H. pylori infections.

    Discussion:

    • H. pylori possesses unique adaptations for survival in the harsh gastric environment.
    • The bacterium employs various virulence factors to interact with and disrupt host epithelial cells.
    • Understanding these mechanisms is crucial for comprehending H. pylori-induced gastroduodenal pathogenesis.

    Key Insights:

    • H. pylori evades host immune responses through sophisticated mechanisms.
    • Virulence factors play a critical role in the bacterium's ability to colonize and damage the gastric mucosa.
    • Chronic inflammation induced by H. pylori contributes significantly to disease development.

    Outlook:

    • Further research into H. pylori virulence factors can identify novel therapeutic targets.
    • Developing strategies to overcome immune evasion is essential for effective treatment.
    • Continued investigation will enhance our understanding of H. pylori's role in gastric carcinogenesis.

    Related Experiment Videos